Loss of MAPK-activated protein kinase 2 enables potent dendritic cell-driven anti-tumour T cell response
Abstract Maintaining dendritic cells (DC) in a state of dysfunction represents a key mechanism by which tumour cells evade recognition and elimination by the immune system. Limited knowledge about the intracellular mediators of DC dysfunction restricts success of therapies aimed at reactivating a DC...
Guardado en:
Autores principales: | Klara Soukup, Angela Halfmann, Barbara Dillinger, Fiona Poyer, Katharina Martin, Bernadette Blauensteiner, Maximilian Kauer, Mario Kuttke, Gernot Schabbauer, Alexander M. Dohnal |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3fe0c65fdfaf40938ede05519f522fc0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity
por: Damya Laoui, et al.
Publicado: (2016) -
Tumour tissue microenvironment can inhibit dendritic cell maturation in colorectal cancer.
por: Adriana J Michielsen, et al.
Publicado: (2011) -
Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells
por: Yinghua Zhao, et al.
Publicado: (2016) -
The tumour microenvironment shapes dendritic cell plasticity in a human organotypic melanoma culture
por: S. Di Blasio, et al.
Publicado: (2020) -
Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy
por: Sandra M. Kallert, et al.
Publicado: (2017)